Hims & Hers Health (HIMS) EPS (Weighted Average and Diluted) (2019 - 2026)

Hims & Hers Health has disclosed EPS (Weighted Average and Diluted) across 8 years of filings, most recently posting -$0.4 for Q1 2026.

• EPS (Weighted Average and Diluted) for Q1 2026 came in at -$0.4, down 300.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.09 (down 113.24% YoY), and the FY2025 annual result was $0.51, down 3.77% from the prior year.
• EPS (Weighted Average and Diluted) came in at -$0.4 for Q1 2026 at Hims & Hers Health, down from $0.08 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.32 in Q3 2024 to a low of -$0.4 in Q1 2026.
• The 5-year median for EPS (Weighted Average and Diluted) is $0.01 (2023), against an average of $0.01.
• Across the five-year window, EPS (Weighted Average and Diluted) soared 900.0% in 2024 and plunged 300.0% in 2026, its largest moves.
• Hims & Hers Health's EPS (Weighted Average and Diluted) stood at -$0.05 in 2022, then surged by 120.0% to $0.01 in 2023, then jumped by 900.0% to $0.1 in 2024, then fell by 20.0% to $0.08 in 2025, then plunged by 600.0% to -$0.4 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at -$0.4 (Q1 2026), $0.08 (Q4 2025), and $0.06 (Q3 2025), per Business Quant data.